<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38594">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025322</url>
  </required_header>
  <id_info>
    <org_study_id>MISP-51163</org_study_id>
    <nct_id>NCT02025322</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS</brief_title>
  <official_title>A Pilot Study Using Randomized, Parallel Design to Compare the Efficacy of Peer Mentoring Versus Standard of Care in Promoting Medication Adherence Among Newly Diagnosed and Medication Non-adherent People Living With HIV/AIDS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jury Candelario</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Apait Health Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the effectiveness of an in-person peer mentoring and health
      literacy intervention on improving medication adherence, HIV-1 viral load, CD4+ T lymphocyte
      counts, and HIV medical appointment attendance among newly-diagnosed and/or medication
      non-adherent HIV-positive individuals, compared to standard of care provider/staff-delivered
      education.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Efficacy of Peer Mentoring on Improving Medication Adherence</measure>
    <time_frame>4 months post-baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Test the efficacy of a peer mentoring intervention on improving medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the Long-Term Impact of Peer Mentoring on Medication adherence</measure>
    <time_frame>6-months post-baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess the long-term impact of peer mentoring on medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Examine the Impact of Peer Mentoring on HIV viral load and CD4 lymphocyte cell counts</measure>
    <time_frame>6-months post-baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compared to standard of care, participants receiving peer mentoring will have significantly lower HIV viral loads and significantly higher CD4 lymphocyte cell counts between baseline and six months post-baseline.</description>
  </other_outcome>
  <other_outcome>
    <measure>Examine the Impact of Peer Mentoring on HIV Medical Appointment Attendance</measure>
    <time_frame>6-months post-baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Examine the impact of peer mentoring on HIV medical appointment attendance among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Between baseline and 4-month follow-up, control group patients will receive current standard of care which includes: (a) two or more HIV basics education and medication adherence counseling sessions with their HIV specialty care provider and Patient Navigator; (b) resource referrals from a Patient Navigator based on the participant's needs (e.g., mental health, substance abuse, social support groups, etc.); and (c) automated medical appointment reminders via phone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peer Mentoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Between baseline and 4-month follow-up, experiment group patients will be receiving (a) Weekly contacts with their Peer Mentor, with the option of receiving more frequent contact, if needed; and (b) 4 monthly, 1-hour workshops on HIV/AIDS, medication adherence, health literacy, and health and wellness. In addition, experiment group participants will also be provided with all standard practice services given to control group participants, including: (c) Two more or HIV basics education and medication adherence counseling sessions with their HIV specialty care provider and Patient Navigator; (d) resource referrals from a Patient Navigator based on the participant's needs; and (e) automated medical appointment reminders via phone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Peer Mentoring</intervention_name>
    <description>Participants in the Peer Mentoring arm will be paired with a Peer Mentor for the duration of the 4-month intervention. Peer Mentors are HIV-positive patients who demonstrate high levels of medication and treatment adherence and are knowledgeable about HIV/AIDS and barriers to care. During the 4-month intervention, Peer Mentors will contact participants weekly via in-person, phone, or email, with the option to provide more frequent contact, if needed. Peer Mentors will provide social support and remind participants to take their medications and attend upcoming medical appointments.
Study participants will also attend four monthly, one hour workshops on HIV/AIDS, medication adherence, health literacy, and health and wellness, which will be developed and co-facilitated by Peer Mentors.</description>
    <arm_group_label>Peer Mentoring</arm_group_label>
    <other_name>Peer-to-peer</other_name>
    <other_name>Community support worker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: All of the following criteria must be met for a participant to be
        eligible for the study:

          -  Confirmed diagnosis of HIV-1

          -  Newly diagnosed and initiating treatment (e.g., treatment naive) OR off medications
             for more than fourteen consecutive days (2 weeks) and re-initiating treatment OR
             currently on antiretroviral therapy with demonstrated ongoing adherence problems
             (missing more than 3 doses per month)

          -  Has a detectable (greater than 50 copies/ml) HIV-1 viral load

          -  Is able to obtain HIV medications during the entire study period (e.g., if uninsured,
             is enrolled in AIDS Drug Assistance Program).

        Exclusion Criteria: Subject is ineligible for this study if:

          -  He/She suffers from cognitive impairment, active psychosis, or has a known history of
             harming others, OR

          -  He/She has a severe mental health and/or substance abuse condition that requires
             residential or inpatient treatment, OR

          -  The medical provider believes participation would not be in the best interest of the
             subject for other reasons.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jury Candelario</last_name>
    <role>Principal Investigator</role>
    <affiliation>Apait Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jordan Lake, M.D., M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Apait Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jordan Lake, M.D., M.Sc.</last_name>
    <phone>310-557-9679</phone>
    <email>jlake@mednet.ucla.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jury Candelario</last_name>
    <phone>213-553-1832</phone>
    <email>jcandelario@apaitonline.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>APAIT Health Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Lake, M.D., M.Sc.</last_name>
      <phone>310-557-9679</phone>
      <email>jlake@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jury Candelario</last_name>
      <phone>213-553-1832</phone>
      <email>jcandelario@apaitonline.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jordan Lake, M.D., M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jury Candelario</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cdc.gov/hiv/topics/surveillance/resources/reports/</url>
    <description>Centers for Disease Control and Prevention (CDC). (2012). HIV Surveillance Report, vol. 22.</description>
  </link>
  <link>
    <url>http://www.cdc.gov/hiv/prevention/research/compendium/ma/peersupport.html</url>
    <description>Peer Support. Compendium of Evidence-Based HIV Behavioral Interventions</description>
  </link>
  <link>
    <url>http://publichealth.lacounty.gov/aids/docs/LAC_FiveYear_ComprehensiveHIVPlan2013-2017.pdf</url>
    <description>Los Angeles County, Department of Public Health. (2013). Five-Year Comprehensive HIV Plan (2013-2017). Los Angeles, CA: Los Angeles County, Department of Public Health</description>
  </link>
  <link>
    <url>http://www.cancer.gov/cancertopics/cancerlibrary/theory.pdf</url>
    <description>National Cancer Institute. (2005). Theory at a Glance: A Guide for Health Promotion Practice. Washington, DC: U.S. Department of Health and Human Services and the National Institutes of Health</description>
  </link>
  <link>
    <url>https://careacttarget.org/library/integrating-peers-hiv-care-and-treatment</url>
    <description>Peer Education and Evaluation Resource (PEER) Center. (HRSA HIV/AIDS Bureau). (2010). Models for Integrating Peers into HIV Care and Treatment [Webinar].</description>
  </link>
  <link>
    <url>http://www.who.int/chp/knowledge/publications/adherence_report/en/</url>
    <description>World Health Organization (WHO). (2003). Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: WHO</description>
  </link>
  <link>
    <url>http://www.who.int/healthpromotion/conferences/7gchp/track2/en/index.html</url>
    <description>WHO. (2009). Track 2: Health literacy and health behavior. 7th Global Conference on Health Promotion. Nairobi, Kenya: WHO</description>
  </link>
  <reference>
    <citation>Bontempi JM, Burleson L, Lopez MH. HIV medication adherence programs: the importance of social support. J Community Health Nurs. 2004 Summer;21(2):111-22.</citation>
    <PMID>15123440</PMID>
  </reference>
  <reference>
    <citation>Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000 Mar 10;14(4):357-66.</citation>
    <PMID>10770537</PMID>
  </reference>
  <reference>
    <citation>Gonzalez JS, Penedo FJ, Antoni MH, Dur√°n RE, McPherson-Baker S, Ironson G, Isabel Fernandez M, Klimas NG, Fletcher MA, Schneiderman N. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004 Jul;23(4):413-8.</citation>
    <PMID>15264978</PMID>
  </reference>
  <reference>
    <citation>Kenya S, Chida N, Symes S, Shor-Posner G. Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature. HIV Med. 2011 Oct;12(9):525-34. doi: 10.1111/j.1468-1293.2011.00921.x. Epub 2011 Apr 24. Review.</citation>
    <PMID>21518221</PMID>
  </reference>
  <reference>
    <citation>Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 Jul 4;133(1):21-30.</citation>
    <PMID>10877736</PMID>
  </reference>
  <reference>
    <citation>Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006 Jan;25(1):74-81.</citation>
    <PMID>16448300</PMID>
  </reference>
  <reference>
    <citation>Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006 Jul 1;194(1):11-9. Epub 2006 Jun 1.</citation>
    <PMID>16741877</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 30, 2013</lastchanged_date>
  <firstreceived_date>December 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Apait Health Center</investigator_affiliation>
    <investigator_full_name>Jury Candelario</investigator_full_name>
    <investigator_title>CEO</investigator_title>
  </responsible_party>
  <keyword>HIV/AIDS</keyword>
  <keyword>Peer Mentoring</keyword>
  <keyword>Medication Adherence</keyword>
  <keyword>Medication Non-adherent</keyword>
  <keyword>Newly diagnosed</keyword>
  <keyword>HIV-positive individuals</keyword>
  <keyword>HIV viral load</keyword>
  <keyword>CD4 lymphocyte cell counts</keyword>
  <keyword>Treatment adherence</keyword>
  <keyword>Health literacy</keyword>
  <keyword>Self-efficacy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
